Cite
microRNA-106b-5p Promotes Cell Growth and Sensitizes Chemosensitivity to Sorafenib by Targeting the BTG3/Bcl-xL/p27 Signaling Pathway in Hepatocellular Carcinoma.
MLA
Enkhnaran, Bilegsaikhan, et al. “MicroRNA-106b-5p Promotes Cell Growth and Sensitizes Chemosensitivity to Sorafenib by Targeting the BTG3/Bcl-XL/P27 Signaling Pathway in Hepatocellular Carcinoma.” Journal of Oncology, Mar. 2022, pp. 1–15. EBSCOhost, https://doi.org/10.1155/2022/1971559.
APA
Enkhnaran, B., Zhang, G.-C., Zhang, N.-P., Liu, H.-N., Wu, H., Xuan, S., Yu, X.-N., Song, G.-Q., Shen, X.-Z., Zhu, J.-M., Liu, X.-P., & Liu, T.-T. (2022). microRNA-106b-5p Promotes Cell Growth and Sensitizes Chemosensitivity to Sorafenib by Targeting the BTG3/Bcl-xL/p27 Signaling Pathway in Hepatocellular Carcinoma. Journal of Oncology, 1–15. https://doi.org/10.1155/2022/1971559
Chicago
Enkhnaran, Bilegsaikhan, Guang-Cong Zhang, Ning-Ping Zhang, Hai-Ning Liu, Hao Wu, Shi Xuan, Xiang-Nan Yu, et al. 2022. “MicroRNA-106b-5p Promotes Cell Growth and Sensitizes Chemosensitivity to Sorafenib by Targeting the BTG3/Bcl-XL/P27 Signaling Pathway in Hepatocellular Carcinoma.” Journal of Oncology, March, 1–15. doi:10.1155/2022/1971559.